Antimicrobial Agents Practice Questions

Q: What is the primary purpose of administering a multidrug regimen for tuberculosis (TB) treatment?

To prevent the development of drug resistance. ***To prevent the development of drug resistance*** - Using multiple drugs simultaneously targets different bacterial pathways, reducing the likelihood of *Mycobacterium tuberculosis* evolving resistance to any single drug [1] - This strategy ensures that even if a few bacteria are naturally resistant to one drug, other drugs in the regimen will eliminate them [1] - This is the fundamental principle behind multidrug TB therapy as per WHO guidelines *To provide broad-spectrum coverage* - TB treatment uses multiple drugs specifically against *Mycobacterium tuberculosis*, not for broad-spectrum coverage [2] - These regimens are tailored to the known characteristics of TB bacteria, not to cover a wide range of pathogens [2] - The drugs used (rifampicin, isoniazid, pyrazinamide, ethambutol) are relatively specific for mycobacteria [2] *To minimize side effects* - Administering multiple anti-TB drugs actually increases the risk of cumulative side effects due to drug interactions and individual toxicities [3] - Each drug has its own toxicity profile (hepatotoxicity, optic neuritis, hyperuricemia) [3] - While side effects are monitored, minimizing them is not the primary reason for multidrug approach *To ensure treatment adherence* - Treatment adherence refers to the patient's consistent use of prescribed medications, not the number of drugs - A complex multidrug regimen can actually make adherence more challenging - Directly Observed Therapy (DOT) is often needed to improve adherence with multidrug regimens

Q: All are true about ciprofloxacin except?

More active at acidic pH. ***More active at acidic pH*** - Fluoroquinolones, including ciprofloxacin, exhibit **reduced antibacterial activity in acidic environments**. Their efficacy is generally better at **neutral or alkaline pH**. - This is clinically relevant as fluoroquinolones may have **reduced effectiveness in acidic sites** like the stomach or acidic urine. - The optimal antibacterial activity occurs at physiological or slightly alkaline pH. *DNA gyrase inhibition* - Ciprofloxacin, like other fluoroquinolones, exerts its antibacterial effect by inhibiting **bacterial DNA gyrase (topoisomerase II)** and **topoisomerase IV**. - This inhibition prevents DNA replication and repair, leading to bacterial cell death. *Contraindicated in pregnancy* - Ciprofloxacin is generally **contraindicated in pregnancy** due to concerns about potential harm to the developing fetus, particularly effects on **cartilage development**. - However, it may be used in specific, life-threatening situations if the benefit outweighs the potential risk. *Second generation fluoroquinolone* - Ciprofloxacin is classified as a **second-generation fluoroquinolone**. - This class includes agents with improved activity against Gram-negative bacteria and some atypical organisms.

Q: What is the recommended dosage for chloroquine chemoprophylaxis in malaria prevention?

500 mg once weekly. ***500 mg once weekly*** - The recommended dosage for chloroquine chemoprophylaxis in malaria prevention is **500 mg salt** (or equivalent to 300 mg base) administered **once weekly**. - This regimen ensures adequate blood concentrations to prevent malarial infection in endemic areas. *500 mg/week* - While the 500 mg dose is correct, simply stating "500 mg/week" without specifying "once weekly" could be misinterpreted. - Chloroquine is generally taken as a **single weekly dose**, not divided doses. *400 mg once weekly* - A dosage of **400 mg** is **sub-therapeutic** for weekly chloroquine chemoprophylaxis. - This dose would likely not provide sufficient protection against malaria. *500 mg BD/week* - Taking chloroquine **twice weekly (BD/week)** at 500 mg is excessive for chemoprophylaxis. - This regimen can lead to increased side effects and toxicity without providing additional prophylactic benefit.

Q: Which of the following drugs is not used for prophylaxis against malaria?

Artesunate. Artesunate - **Artesunate** is a **fast-acting artemisinin derivative primarily used for treating acute malaria infections, especially severe or complicated cases**, and is not recommended for prophylaxis [4]. - Its short half-life and rapid clearance make it unsuitable for preventing malaria, as it would require frequent dosing, which is impractical for long-term prevention. *Doxycycline* - **Doxycycline** is an **antibiotic** that can be used for malaria prophylaxis, particularly in areas with **chloroquine-resistant P. falciparum** [1]. - It works by inhibiting protein synthesis in the parasite and must be taken daily, starting before travel and continuing for a period after returning [1]. *Chloroquine* - **Chloroquine** was historically a cornerstone for malaria prophylaxis due to its effectiveness and low cost, particularly in areas with **sensitive Plasmodium species.** [2] - However, widespread **chloroquine resistance**, especially in **P. falciparum**, has limited its current use for prophylaxis to specific regions where resistance is not prevalent [2]. *Mefloquine* - **Mefloquine** is an **antimalarial drug** commonly used for prophylaxis, especially in areas with **chloroquine-resistant P. falciparum** [2], [3]. - It is known for its convenience of once-weekly dosing but can have significant **neuropsychiatric side effects**, limiting its use in some individuals [3].

Q: Which of the following is not used as treatment for lymphatic filariasis -

Praziquantel. ***Praziquantel*** - **Praziquantel** is primarily an **anthelmintic drug** effective against **schistosomiasis** and **tapeworm infections**. - It does not have a significant role in the treatment of **lymphatic filariasis**. *Ivermectin* - **Ivermectin** is one of the **mainstays** of treatment for **lymphatic filariasis**, particularly in combination therapies. - It works by paralyzing and killing **microfilariae**, reducing their numbers in the bloodstream. *DEC* - **Diethylcarbamazine (DEC)** is a **highly effective antifilarial drug** used to kill both **microfilariae** and **adult worms** in lymphatic filariasis. - It is often used in mass drug administration programs and for individual treatment. *Albendazole* - **Albendazole** is an **anthelmintic drug** often used in combination with **Ivermectin** or **DEC** for the treatment of **lymphatic filariasis**. - It helps to kill **microfilariae** and has some macrofilaricidal effects, reducing the viability of adult worms.

Q: What is the primary reason for using a combination of four drugs in Anti-Koch's Treatment (AKT) for tuberculosis?

To decrease the risk of resistance due to mutation.. ***To decrease the risk of resistance due to mutation*** - **Tuberculosis bacteria** can spontaneously develop resistance to a single drug through **random genetic mutations**. - Using multiple drugs simultaneously significantly reduces the probability that a bacterium will spontaneously develop resistance to **all drugs** in the regimen. - This is the **primary rationale** for multi-drug therapy in TB, as emphasized by WHO guidelines. *To decrease the risk of resistance due to conjugation* - **Conjugation** is a mechanism of horizontal gene transfer in bacteria, primarily involving the transfer of plasmids. - While important for antibiotic resistance in some bacteria, it is **not the primary mechanism** of resistance development in *Mycobacterium tuberculosis*. - TB resistance develops mainly through **chromosomal mutations**, not plasmid transfer. *To enhance overall treatment efficacy* - While multi-drug regimens do enhance treatment efficacy by targeting different bacterial populations (actively dividing, slow-growing, dormant), this is a **consequence** of the multi-drug approach. - The **primary reason** for using four drugs specifically is to prevent the emergence of **drug-resistant mutants**. - Enhanced efficacy is achieved *because* resistance is prevented, making this a secondary benefit. *To simplify treatment* - A four-drug regimen actually makes treatment more **complex** due to multiple pills, potential drug interactions, and increased side effects. - The complexity is a necessary trade-off for **resistance prevention** and treatment success.

Q: As per RNTCP guidelines, Multi drug resistance (MDR) TB is defined as resistance to:

Rifampicin and isoniazid. ***Rifampicin and isoniazid*** - According to **RNTCP guidelines** (now NTEP), **MDR-TB** is specifically defined as tuberculosis that is resistant to at least both **rifampicin** and **isoniazid**. - These two drugs are the **most potent first-line anti-TB medications**, and resistance to both significantly complicates treatment. *Rifampicin* - While resistance to **rifampicin alone** is a serious concern, it is classified as **rifampicin-resistant TB (RR-TB)**, not full **MDR-TB**. - **MDR-TB** requires resistance to at least two key first-line drugs. *Rifampicin, isoniazid and ethambutol* - Resistance to **rifampicin**, **isoniazid**, and **ethambutol** would be a form of **MDR-TB** (as it includes resistance to rifampicin and isoniazid), but it is a more extensive form of resistance. - The minimum definition of **MDR-TB** focuses on the two most crucial first-line drugs. *None of the above* - This option is incorrect because there is a specific definition for **MDR-TB** that aligns with one of the provided choices. - The guidelines clearly define **MDR-TB** based on resistance to specific drugs.

Q: Which sulphonamide has the longest acting duration?

Sulphadoxine. ***Sulphadoxine*** - **Sulphadoxine** is known for its **exceptionally long elimination half-life**, which is due to its high plasma protein binding and slow renal excretion. - This property allows for **once-weekly dosing**, making it one of the longest-acting sulfonamides, often used in combinations for malaria prophylaxis or treatment. *Sulfadiazine* - **Sulfadiazine** has an intermediate half-life, typically requiring **multiple daily doses**. - It is commonly used for infections like **toxoplasmosis** and **nocardiosis**. *Sulfamethoxazole* - **Sulfamethoxazole** has an intermediate half-life, usually requiring **twice-daily administration**. - It is most famously co-formulated with **trimethoprim** (as co-trimoxazole) for a broad range of bacterial infections. *Sulfamethiazole* - **Sulfamethiazole** is a **short-acting sulfanilamide derivative** with a rapid elimination, meaning it would require frequent dosing. - It is not commonly used systemically due to its short duration of action.

Q: Which of the following antibiotics is known to cause bleeding due to its effect on blood clotting?

Moxalactam. Moxalactam - Moxalactam is a **third-generation cephalosporin** known to cause **hypoprothrombinemia** and platelet dysfunction, leading to an increased risk of bleeding. - This effect is due to its **N-methylthiotetrazole (NMTT) side chain**, which inhibits vitamin K-dependent clotting factor synthesis. Cefaloridine - This is a **first-generation cephalosporin** that does not have the NMTT side chain and is not commonly associated with significant bleeding risks. - Its primary adverse effect of concern is **nephrotoxicity** at high doses, rather than coagulopathy. Ceftazidime - Ceftazidime is a **third-generation cephalosporin** primarily used for *Pseudomonas aeruginosa* infections but does **not contain the NMTT side chain** responsible for bleeding complications. - While broad-spectrum, it generally has a favorable safety profile concerning coagulation. *Cefazolin* - Cefazolin is a **first-generation cephalosporin** [1] widely used for surgical prophylaxis and skin infections [1], and it does **not interfere with coagulation** pathways. - Its main side effects are typical for penicillin-related antibiotics, such as hypersensitivity reactions [1],[2].

Q: Sulphonamide injection causes decrease in folic acid by?

Inhibition through competition with substrate. ***Inhibition through competition with substrate***Sulphonamides are **structural analogs of p-aminobenzoic acid (PABA)**, a substrate crucial for dihydropteroate synthase [1, 2]. They competitively inhibit this enzyme, which synthesizes **dihydrofolic acid**, a precursor to **tetrahydrofolic acid (THF)**, thereby reducing folic acid production in bacteria [1, 2].*Inhibition without competition*This typically refers to **non-competitive inhibition**, where the inhibitor binds to an allosteric site and changes the enzyme's conformation, regardless of substrate concentration. Sulphonamides, however, specifically compete with PABA at the active site of **dihydropteroate synthase**.*Inhibition through a different site*This describes **allosteric inhibition** or non-competitive inhibition, where the inhibitor binds to a site other than the active site. Sulphonamides do not work through an allosteric mechanism; they directly interfere with the binding of PABA at the enzyme's active site.*Inhibition that does not involve the active site*This is another way to describe **non-competitive** or **allosteric inhibition**, where the inhibitor binds elsewhere on the enzyme, altering its function without directly blocking the active site. Sulphonamides' mechanism is distinct, as they closely resemble the natural substrate and directly compete for the active site of **dihydropteroate synthase**.

Question 1

What is the primary purpose of administering a multidrug regimen for tuberculosis (TB) treatment?

Accepted Answer

To prevent the development of drug resistance

Answer

To provide broad-spectrum coverage

Answer

To minimize side effects

Answer

To ensure treatment adherence

Question 2

All are true about ciprofloxacin except?

Accepted Answer

More active at acidic pH

Answer

DNA gyrase inhibition

Answer

Contraindicated in pregnancy

Answer

Second generation fluoroquinolone

Question 3

What is the recommended dosage for chloroquine chemoprophylaxis in malaria prevention?

Accepted Answer

500 mg once weekly

Answer

500 mg/week

Answer

400 mg once weekly

Answer

500 mg BD/week

Question 4

Which of the following drugs is not used for prophylaxis against malaria?

Accepted Answer

Artesunate

Answer

Doxycycline

Answer

Mefloquine

Answer

Chloroquine

Question 5

Which of the following is not used as treatment for lymphatic filariasis -

Accepted Answer

Praziquantel

Answer

DEC

Answer

Albendazole

Answer

Ivermectin

Question 6

What is the primary reason for using a combination of four drugs in Anti-Koch's Treatment (AKT) for tuberculosis?

Accepted Answer

To decrease the risk of resistance due to mutation.

Answer

To decrease the risk of resistance due to conjugation.

Answer

To enhance overall treatment efficacy.

Answer

To simplify treatment.

Question 7

As per RNTCP guidelines, Multi drug resistance (MDR) TB is defined as resistance to:

Accepted Answer

Rifampicin and isoniazid

Answer

Rifampicin

Answer

Rifampicin, isoniazid and ethambutol

Answer

None of the above

Question 8

Which sulphonamide has the longest acting duration?

Accepted Answer

Sulphadoxine

Answer

Sulfadiazine

Answer

Sulfamethoxazole

Answer

Sulfamethiazole

Question 9

Which of the following antibiotics is known to cause bleeding due to its effect on blood clotting?

Accepted Answer

Moxalactam

Answer

Cefaloridine

Answer

Cefazolin

Answer

Ceftazidime

Question 10

Sulphonamide injection causes decrease in folic acid by?

Accepted Answer

Inhibition through competition with substrate

Answer

Inhibition without competition

Answer

Inhibition through a different site

Answer

Inhibition that does not involve the active site

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?